Article
CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy
17 Aug 2018
Abstract excerpt
Molecularly, breast cancer represents a highly heterogenous family of neoplastic disorders, with substantial interpatient variations regarding genetic mutations, cell composition, transcriptional profiles, and treatment response. Consequently, there is an increasing demand for alternative diagnostic approaches aimed at the molecular annotation of the disease on a patient-by-patient basis and the design of more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
